SOX9 and melanoma: In agreement with this notion, our reporter and ChIP assays suggest that the human NEDD9 promoter sequence favors the binding and transactivation capacity by SOX10 whereas the high level of SOX9 expression is required for efficient activation of NEDD9 expression in both parental and SOX10 KD melanoma cells.